Literature DB >> 32575815

Bioinformatics Approach for Identifying Novel Biomarkers and Their Signaling Pathways Involved in Interstitial Cystitis/Bladder Pain Syndrome with Hunner Lesion.

Subbroto Kumar Saha1, Tak-Il Jeon1, Soo Bin Jang1, Se Jong Kim1, Kyung Min Lim1, Yu Jin Choi1, Hyeong Gon Kim2, Aram Kim2, Ssang-Goo Cho1.   

Abstract

The complexity of interstitial cystitis/bladder pain syndrome (IC/BPS) has led to considerable uncertainty in terms of diagnosis and prevalence of the condition. Here, we try to identify the IC/BPS-associated genes through an integrated analysis of Gene Expression Omnibus (GEO) datasets and confirm experimentally to predict the pathologic diagnosis of IC/BPS. Data mining analysis of GEO datasets (GSE621, GSE11783, GSE28242, and GSE57560) revealed a total of 53 (51 upregulated and two downregulated) common differentially expressed genes (DEGs) in IC/BPS. A protein-protein interaction (PPI) network was then constructed with the 53 common DEGs using Cytoscape v3.7.2, and subsequently, six hub genes (CD5, CD38, ITGAL, IL7R, KLRB1, and IL7R) were identified using cytoHubba v0.1 that were upregulated in IC/BPS. Enrichment analysis of common DEGs revealed that hematopoietic cell lineage, immune system, and T-cell receptor (TCR) signaling in naïve CD4+ T cell signaling pathways were prominently involved with the common 51 upregulated DEGs. The two common downregulated DEGs may enrich linoleic acid metabolism and synthesis of epoxy (EET) and dihydroxyeicosatrienoic acid (DHET) signaling pathways in IC/BPS. Moreover, our RT-PCR data confirmed that the expression of the five hub genes (CD38, ITGAL, IL7R, KLRB1, and IL7R) was significantly augmented in IC/BPS patients' samples when compared with their normal counterparts. In this study, we systematically predict the significant biomarkers and possible signaling pathways involved in IC/BPS, confirming the differential expression of the hub genes in tissue samples from patients with IC/BPS. Thus, the hub genes might be used as potential diagnostic biomarkers of IC/BPS.

Entities:  

Keywords:  bioinformatics; biomarkers; bladder pain syndrome; diagnosis; interstitial cystitis; signaling pathway

Year:  2020        PMID: 32575815     DOI: 10.3390/jcm9061935

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  4 in total

Review 1.  The Roles of T cells in Bladder Pathologies.

Authors:  Jianxuan Wu; Soman N Abraham
Journal:  Trends Immunol       Date:  2021-02-01       Impact factor: 16.687

2.  MiR-487b suppressed inflammation and neuronal apoptosis in spinal cord injury by targeted Ifitm3.

Authors:  Dake Tong; Yanyin Zhao; Yang Tang; Jie Ma; Miao Wang; Bo Li; Zhiwei Wang; Cheng Li
Journal:  Metab Brain Dis       Date:  2022-07-08       Impact factor: 3.655

3.  WGCNA-Based Identification of Hub Genes and Key Pathways Involved in Nonalcoholic Fatty Liver Disease.

Authors:  Folai Zeng; Meijie Shi; Huanming Xiao; Xiaoling Chi
Journal:  Biomed Res Int       Date:  2021-12-13       Impact factor: 3.411

4.  Defining Molecular Treatment Targets for Bladder Pain Syndrome/Interstitial Cystitis: Uncovering Adhesion Molecules.

Authors:  Guldal Inal-Gultekin; Zeliha Gormez; Naside Mangir
Journal:  Front Pharmacol       Date:  2022-03-25       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.